The Role of Endothelin-B Receptors in Myocardial and Endothelial Reperfusion Injury After Heart Transplantation[*]

Background: This study was designed to investigate the effects of the selective endothelin-B (ET-B) receptor agonist IRL1620 and the selective ET-B receptor antagonist BQ788 on myocardial and endothelial function after reversible deep hypothermic ischemia and reperfusion. Methods: Isogenic intraabdominal heterotopic heart transplantation was performed on Lewis rats. After one hour of cold ischemic preservation, reperfusion was started either after application of saline vehicle or IRL1620 or BQ788 or both. Left ventricular pressure-volume relations and myocardial blood flow were assessed after one and 24 hours of reperfusion. Endothelium-dependent vasodilatation to acetylcholine (ACH) and endothelium-independent vasodilatation to sodium nitroprusside (SNP) were also determined. Results: IRL1620 attenuated and BQ788 improved myocardial contractility significantly as indicated by the left or upward shift of the systolic pressure-volume relation, respectively, and significantly changed myocardial blood flow during early reperfusion (p < 0.05). Although myocardial function and baseline myocardial blood flow were similar in both groups after 24 hours of reperfusion, endothelium-dependent vasodilatation was still significantly lower in the IRL1620 and higher in the BQ788 group (p < 0.05). Conclusions: These results suggest that activation of the ET-B receptors contributes to reperfusion injury after cardiac preservation in a rat heart transplant model.

Key words:

Endothelin-antagonist - Reperfusion - Contractile function - Rheology - Endothelial function - Heart transplantation

1 The paper was presented at the Annual Meeting of the Austrian, German and Swiss Societies of the Thoracic and Cardiovascular Surgery in 2000, in Luzerne.

References

• 1 Yanasigawa M, Kurihara H, Kimura S. et al . A novel potent vasoconstrictor peptid produced by vascular endothelial cells.  Nature. 1988;  332 411-415
• 2 Yasuda M, Kohno M, Tahara A. et al . Circulating immunoreactive endothelin in ischemic heart disease.  Am Heart J. 1990;  119 801-806
• 3 Cannan C R, Burnett J C, Lermann A. Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure.  Circulation. 1996;  93 646-651
• 4 Wang Q-D, Hemsen A, Li X -S, Lundberg J M, Uriuda Y, Pernow J. Local overflow and enhanced tissue content of endothelin following myocardial ischaemia and reperfusion in the pig: modulation by L-arginine.  Cardiovasc Res. 1995;  29 44-49
• 5 Masaki T, Kimura S, Yanagisawa M, Goto K. Moleculer and cellular mechanisms of endothelial regulation: implications for vascular function.  Circulation. 1991;  84 1457-1468
• 6 Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, Marumo F. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells.  J Clin Invest. 1993;  91 1367-1373
• 7 Saijonmaa O, Nyman T, Fryhrquist F. Endothelin-1 stimulates its own synthesis in human endothelial cells.  Biochem Biophys Res Commun. 1992;  286-291
• 8 Rasmussen T E, Jougasaki M, Supaporn T, Hallett J W, Brooks D P, Burnett J C. Cardiovascular actions of ET-B activation in vivo and modulation by receptor antagonism.  Am J Physiol. 1998;  274 R131-R138
• 9 McMurdo L, Corder R, Thiemermann C, Vane J R. Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor.  Br J Pharmacol. 1993;  108 557-561
• 10 Seo B, Oemar B S, Siebenmann R, von Segesser L, Lüscher T F. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.  Circulation. 1994;  89 1203-1208
• 11 Li X -S, Wang Q -D, Pernow J. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endocardial injury following ischemia/reperfusion in the rat.  Eur J Pharmacol. 1995;  283 161-168
• 12 Szabó G, Bátkai S, Bährle S, Dengler T J, Vahl C F, Zimmermann R, Hagl S. Effects of nitric oxide synthesis on reperfusion injury and catecholamine responsiveness in a heterotopic rat heart-transplantation model.  J Cardiovasc Pharm. 1998;  31 221-230
• 13 Brunner F. Tissue endothelin-1 levels in perfused rat heart following stimulation with agonists and in ischemia and reperfusion.  J Mol Cell Cardiol. 1995;  27 1953-1963
• 14 Wang Q -D, Li X -S, Lundberg J M, Pernow J. Protective effect of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig.  Cardiovasc Res. 1995;  29 805-812
• 15 Tonessen T, Giaid A, Saleh D, Naess P A, Yanagisawa M, Christensen G. Increased in vivo expression and production of endothelin-1 by porcine cardiomyocytes subjected to ischemia.  Circ Res. 1995;  76 767-772
• 16 Han H, Neubauer B, Ertl G. Endothelin-1 contributes to ischemia/reperfusion injury in isolated rat heart - Attenuation of ischemic injury by the endothelin antagonists BQ123 and BQ610.  J Moll Cell Cardiol. 1995;  27 761-766
• 17 Hiramtsu T, Forbess J, Miura T, Roth S J, Cioffi M A, Mayer J E. Effects of endothelin-1 and endothelin-A receptor antagonist on recovery after hypothermic cardioplegic ischemia in neonatal lamb hearts.  Circulation. 1995;  Suppl II 400-404
• 18 Iimuro M, Kaneko M, Matsumoto Y, Fujise Y, Watanabe T, Hayashi H. Effects of an endothelin receptor antagonist TAK-044 on myocardial energy metabolism in ischemia/reperfused rat hearts.  J Cardiovasc Pharmacol. 2000;  35 403-409
• 19 Szabó G, Fazekas L, Bährle S, Macdonald D, Stumpf N, Vahl C F, Hagl S. Endothelin-A and -B antagonist protect myocardial and endothelial function after ischemia/reperfusion in a rat heart transplantation model.  Cardiovasc Res. 1998;  39 683-690
• 20 Peter M G, Davenport A P. Characterization of the endothelin receptor selective agonist BQ3020 and antagonist BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart.  Br J Pharmacol. 1996;  117 455-462
• 21 Filep J G, Clozel M, Fournier A, Földes-Filep E. Characterization of receptors mediating vascular responses to endothelin-1 in the conscious rat.  Br J Pharmacol. 1994;  113 845-852
• 22 Filep J G, Skrobik Y, Fournier A, Földes-Filep E. Effects of calcium antagonists on endothelin-l-induced myocardial ischemia and oedema in the rat.  Br J Pharmacol. 1996;  118 893-900
• 23 Balwierczak J L. Two subtypes of endothelin receptor (ETA and ETB) mediate vasoconstriction in the perfused rat heart.  J Cardiovasc Pharmacol. 1993;  22 (suppl. 8) 5248-5251
• 24 Zaugg C E, Hornstein P S, Zhu P, Simper D, Luscher T F, Allegrini P R, Buser P T. Endothelin-1-induced release of thromboxane AZ increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts.  Circulation. 1996;  94 742-747
• 25 López-Farre A, Riesco A, Epispinosa G ,. et al . Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart.  Circulation. 1993;  88 1166-1171
• 26 Ishida K, Takeshige K, Minakami S. Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucylphenylalanin.  Biochem Biophys Res Commun. 1990;  173 496-500
• 27 Griswold D E, Douglas S A, Martin L D. et al . Endothelin B receptor modulates inflammatory pain and cutaneous inflammation.  Mol Pharmacol. 1999;  56 807-812

1 The paper was presented at the Annual Meeting of the Austrian, German and Swiss Societies of the Thoracic and Cardiovascular Surgery in 2000, in Luzerne.